| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | salermide:PLX-4032 (12:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.19 | 3e-06 |
| mRNA | dabrafenib | CTRPv2 | pan-cancer | AAC | 0.24 | 5e-06 |
| mRNA | PLX4720 | CTRPv2 | pan-cancer | AAC | 0.17 | 2e-05 |
| mRNA | Panobinostat | CCLE | pan-cancer | AAC | -0.19 | 3e-05 |
| mRNA | KPT185 | CTRPv2 | pan-cancer | AAC | -0.16 | 0.0003 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | -0.19 | 0.0004 |
| mRNA | BRD-K34485477 | CTRPv2 | pan-cancer | AAC | 0.27 | 0.0005 |
| mRNA | ciclopirox | CTRPv2 | pan-cancer | AAC | -0.12 | 0.0006 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.2 | 0.0009 |
| mRNA | CD-437 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.001 |